Episode 32: The Story of GlaxoSmithKline and the Importance of Design In Healthtech 🧬

James is joined by Andrew Barraclough, VP of design and innovation at GlaxoSmithKline. With thirty years’ experience, Andrew Barraclough is a leading voice at the heart of design and innovation in the healthcare and FMCG sectors. Andrew joined GlaxoSmithKline in 2011, having previously worked Design Business Association, Novartis Consumer Health, Reckitt Benckiser and Pure Realisation, which he founded. As Vice President of design and innovation at GSK, Andrew has continued to push the boundaries of perception of design across 146+ markets for 25+ global brands, including Panadol, Sensodyne, Theraflu and Flonase. Andrew’s mission at GSK is to embed world class design-thinking and culture across all customer touchpoints. Andrew and James talk about the importance of design in healthtech, how to apply design thinking, the value of designers to healthtech startups and all startups need to apply design thinking from day one. https://www.gsk.com/